Showing results (661-670 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|December 15, 2018
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challengingYang Li, Feng Sun, Wenhong Zhang
Drug Development Research|July 13, 2026
Ameliorative Effects of a Naphthoquinone Derivative With β-Amyloid Aggregation Inhibitory Activity on Cognitive Impairment and Metabolite Analysis of the Blood and Brains of MiceJong Min Oh, Won Kyeong Jeong, Hyun Ju Son, et al.
Drug Development Research|July 8, 2026
Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug RepurposingAyush Dubey, Ayush Chaurasia, Zeeshan Ansari, et al.
Drug Development Research|March 28, 2026
FGF18 Ameliorates HIV-1 Tat-Induced Blood-Brain Barrier Disruption via Wnt/β-Catenin SignalingPengfei Zhang, Song Wei, Fanyu Fu, et al.
Drug Development Research|April 20, 2026
Targeting Alpha-Synuclein Aggregation With Chemical Chaperone IP-045: An Approach to Parkinson's Disease TherapyNavpreet Kaur, Rimaljot Singh, Neelima Dhingra, et al.
Drug Development Research|April 20, 2026
Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical InnovationMohd Shoab Ali, Taha Alqahtani, Humood Al Shmrany, et al.
Drug Development Research|April 30, 2026
Design, Green Synthesis, and Biological Evaluation of Novel Triaryl-Tethered Acryloyl Derivatives as New Generation β-Tubulin Inhibitors for Hepatocellular Carcinoma TreatmentAamal A Al-Mutairi, Mai A E Mourad, Arwa Sultan Alqahtani, et al.
Drug Development Research|March 29, 2026
Synthesis, Characterization, and Biological Evaluation of Aliphatic-Substituted Benzimidazole Derivatives: Induction of Apoptosis, Cell Cycle Arrest, and Molecular Docking in Breast Cancer CellsMurat Keser, Çisil Çamlı Pulat, Harika Atmaca, et al.
Drug Development Research|March 29, 2026
Heteromerization, Biased Agonism, and Allosteric Modulation of G Protein-Coupled Receptors in Addiction: Mechanistic Insights and Therapeutic ImplicationsKhaled A Alhosaini, Mohammed M Alanazi, Ibrahim N Alsulaihim, et al.
Drug Development Research|April 2, 2026
A LAT1-Compatible, Leadlike Tyrosine-Naphthoquinone Conjugate With Anticancer ActivityAustin Seymour, Christian Peterson, Raymond Osafo, et al.
Pageof 140